Literature DB >> 28416538

Susceptibility Testing of Common and Uncommon Aspergillus Species against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method.

Enrica Mello1, Brunella Posteraro2, Antonietta Vella1, Elena De Carolis1, Riccardo Torelli1, Tiziana D'Inzeo1, Paul E Verweij3, Maurizio Sanguinetti4.   

Abstract

We tested 59 common and 27 uncommon Aspergillus species isolates for susceptibility to the mold-active azole antifungal agents itraconazole, voriconazole, and posaconazole using the Sensititre method. The overall essential agreement with the CLSI reference method was 96.5% for itraconazole and posaconazole and was 100% for voriconazole. By the Sensititre method as well as the CLSI reference method, all of 10 A. fumigatus isolates with a cyp51 mutant genotype were classified as being non-wild-type isolates (MIC > epidemiological cutoff value [ECV]) with respect to triazole susceptibility.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Aspergillus; Sensititre; antifungal susceptibility testing

Mesh：

Substances：

Year:  2017        PMID： 28416538      PMCID： PMC5444134          DOI： 10.1128/AAC.00168-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  26 in total

Review 1.  Emerging moulds: epidemiological trends and antifungal resistance.

Authors:  Marisa H Miceli; Samuel A Lee
Journal:  Mycoses       Date:  2011-06-14       Impact factor: 4.377

Review 2.  The future of fungal susceptibility testing.

Authors:  Brunella Posteraro; Maurizio Sanguinetti
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

Review 3.  Epidemiology of invasive mycoses in North America.

Authors:  Michael A Pfaller; Daniel J Diekema
Journal:  Crit Rev Microbiol       Date:  2010       Impact factor: 7.624

Review 4.  Previously unknown species of Aspergillus.

Authors:  M Gautier; A-C Normand; S Ranque
Journal:  Clin Microbiol Infect       Date:  2016-06-02       Impact factor: 8.067

Review 5.  The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds.

Authors:  Ana Espinel-Ingroff; John Turnidge
Journal:  Rev Iberoam Micol       Date:  2016-06-11       Impact factor: 1.044

6.  Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.

Authors:  Michael A Pfaller; Shawn A Messer; Leah N Woosley; Ronald N Jones; Mariana Castanheira
Journal:  J Clin Microbiol       Date:  2013-05-29       Impact factor: 5.948

7.  Aspergillosis due to voriconazole highly resistant Aspergillus fumigatus and recovery of genetically related resistant isolates from domiciles.

Authors:  Jan W M van der Linden; Simone M T Camps; Greetje A Kampinga; Jan P A Arends; Yvette J Debets-Ossenkopp; Pieter J A Haas; Bart J A Rijnders; Ed J Kuijper; Frank H van Tiel; János Varga; Anna Karawajczyk; J Zoll; Willem J G Melchers; Paul E Verweij
Journal:  Clin Infect Dis       Date:  2013-05-10       Impact factor: 9.079

Review 8.  Breakpoints for antifungal agents: an update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

Authors:  Maiken C Arendrup; Manuel Cuenca-Estrella; Cornelia Lass-Flörl; William W Hope
Journal:  Drug Resist Updat       Date:  2014-01-27       Impact factor: 18.500

Review 9.  Azole Resistance in Aspergillus fumigatus: Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

Authors:  Paul E Verweij; Anuradha Chowdhary; Willem J G Melchers; Jacques F Meis
Journal:  Clin Infect Dis       Date:  2015-10-20       Impact factor: 9.079

Review 10.  Antifungal susceptibility testing: current role from the clinical laboratory perspective.

Authors:  Brunella Posteraro; Riccardo Torelli; Elena De Carolis; Patrizia Posteraro; Maurizio Sanguinetti
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-04-07       Impact factor: 2.576
View more
  10 in total

Review 1.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

2.  Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values.

Authors:  A Espinel-Ingroff; J Turnidge; A Alastruey-Izquierdo; E Dannaoui; G Garcia-Effron; J Guinea; S Kidd; T Pelaez; M Sanguinetti; J Meletiadis; F Botterel; B Bustamante; Y-C Chen; A Chakrabarti; A Chowdhary; E Chryssanthou; S Córdoba; G M Gonzalez; J Guarro; E M Johnson; J V Kus; C Lass-Flörl; M J Linares-Sicilia; E Martín-Mazuelos; C E Negri; M A Pfaller; A M Tortorano
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

3.  Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods.

Authors:  A Espinel-Ingroff; J Turnidge; A Alastruey-Izquierdo; F Botterel; E Canton; C Castro; Y-C Chen; Y Chen; E Chryssanthou; E Dannaoui; G Garcia-Effron; G M Gonzalez; N P Govender; J Guinea; S Kidd; M Lackner; C Lass-Flörl; M J Linares-Sicilia; L López-Soria; R Magobo; T Pelaez; G Quindós; M A Rodriguez-Iglesia; M A Ruiz; F Sánchez-Reus; M Sanguinetti; R Shields; P Szweda; A Tortorano; N L Wengenack; S Bramati; C Cavanna; C DeLuca; M Gelmi; A Grancini; G Lombardi; J Meletiadis; C E Negri; M Passera; J Peman; A Prigitano; E Sala; M Tejada
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

Review 4.  Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside.

Authors:  Justin Beardsley; Catriona L Halliday; Sharon C-A Chen; Tania C Sorrell
Journal:  Future Microbiol       Date:  2018-08-16       Impact factor: 3.165

5.  Strengthening the One Health Agenda: The Role of Molecular Epidemiology in Aspergillus Threat Management.

Authors:  Eta E Ashu; Jianping Xu
Journal:  Genes (Basel)       Date:  2018-07-19       Impact factor: 4.096

6.  Chaetomium atrobrunneum causing human eumycetoma: The first report.

Authors:  Najwa A Mhmoud; Antonella Santona; Maura Fiamma; Emmanuel Edwar Siddig; Massimo Deligios; Sahar Mubarak Bakhiet; Salvatore Rubino; Ahmed Hassan Fahal
Journal:  PLoS Negl Trop Dis       Date:  2019-05-30

7.  The effect of lichen secondary metabolites on Aspergillus fungi.

Authors:  Łukasz Furmanek; Paweł Czarnota; Mark R D Seaward
Journal:  Arch Microbiol       Date:  2021-12-29       Impact factor: 2.552

8.  Multicenter Italian Study on "In Vitro Activities" of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for Aspergillus Species: Comparison between SensititreTM YeastOneTM and MIC Test Strip.

Authors:  Giuliana Lo Cascio; Alda Bazaj; Laura Trovato; Silvana Sanna; Stefano Andreoni; Elisabetta Blasi; Marco Conte; Paolo Fazii; Ester Oliva; Valentina Lepera; Gianluigi Lombardi; Claudio Farina
Journal:  Infect Drug Resist       Date:  2022-10-04       Impact factor: 4.177

Review 9.  Susceptibility Testing of Fungi to Antifungal Drugs.

Authors:  Maurizio Sanguinetti; Brunella Posteraro
Journal:  J Fungi (Basel)       Date:  2018-09-15

10.  Drug-Resistant Aspergillus flavus Is Highly Prevalent in the Environment of Vietnam: A New Challenge for the Management of Aspergillosis?

Authors:  Tra My N Duong; Phuong Tuyen Nguyen; Thanh Van Le; Huong Lan P Nguyen; Bich Ngoc T Nguyen; Bich Phuong T Nguyen; Thu Anh Nguyen; Sharon C-A Chen; Vanessa R Barrs; Catriona L Halliday; Tania C Sorrell; Jeremy N Day; Justin Beardsley
Journal:  J Fungi (Basel)       Date:  2020-11-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.